Lipid clustering by three homologous arginine-rich antimicrobial peptides is insensitive to amino acid arrangement and induced secondary structure

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 6, 2010, Pages 1272-1280

  Epand, Richard M ^a   Epand, Raquel F ^a   Arnusch, Christopher J ^b   Papahadjopoulos Sternberg, Brigitte ^c   Wang, Guangshun ^d   Shai, Yechiel ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c NanoAnalytical Laboratory   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antibacterial peptides; Bacterial species specificity; Differential scanning calorimetry; Freeze fracture electron microscopy; Lipid clustering; Membrane domains

Indexed keywords

ARGININE; ARGINYLARGINYLPROPYLPHENYLALANYLTRYPTOPHYLISOLEUCYLISOLEUCYLARGINYLARGINYLAMIDE; LYSYLARGINYLISOLEUCYLVALYLGLUTAMINYLARGINYLISOLEUCYLLYSYLASPARTYLPHENYLALANYLLEUCYLARGINYLAMIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PROPYLARGINYLPHENYLALANYLARGINYLTRYPTOPHYLARGINYLISOLEUCYLARGINYLISOLEUCYLAMIDE; PROPYLPHENYLALANYLTRYPTOPHYLARGINYLISOLEUCYLARGINYLISOLEUCYLARGINYLARGINYLAMIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS MEGATERIUM; BACTERIAL MEMBRANE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FREEZE FRACTURE; LIPID COMPOSITION; MEMBRANE STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANTI-INFECTIVE AGENTS; CATHELICIDINS; CELL MEMBRANE; GRAM-POSITIVE BACTERIA; HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE LIPIDS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 77952549044     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.03.012     Document Type: Article

References (43)

1. Zhang L., Rozek A., Hancock R.E. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 2001, 276:35714-35722.
2. Giacometti A., Cirioni O., Greganti G., Quarta M., Scalise G. In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria. Antimicrob. Agents Chemother. 1998, 42:3320-3324.
3. Melo M.N., Ferre R., Castanho M.A. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat. Rev. Microbiol. 2009, 7:245-250.
4. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 2006, 8:11-26.
5. Roy H. Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol. IUBMB Life 2009, 61:940-953.
6. Chen F.Y., Lee M.T., Huang H.W. Sigmoidal concentration dependence of antimicrobial peptide activities: a case study on alamethicin. Biophys. J. 2002, 82:908-914.
7. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1998, 1376:391-400.
8. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002, 66:236-248.
9. Yang L., Gordon V.D., Mishra A., Som A., Purdy K.R., Davis M.A., Tew G.N., Wong G.C.L. Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes. J. Am. Chem. Soc. 2007, 129:12141-12147.
10. Epand R.F., Sarig H., Mor A., Epand R.M. Cell-wall interactions and the selective bacteriostatic activity of a miniature oligo-acyl-lysyl. Biophys. J. 2009, 97:2250-2257.
11. Marchand C., Krajewski K., Lee H.F., Antony S., Johnson A.A., Amin R., Roller P., Kvaratskhelia M., Pommier Y. Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res. 2006, 34:5157-5165.
12. Breukink E., Wiedemann I., van Kraaij C., Kuipers O.P., Sahl H.G., de Kruijff B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999, 286:2361-2364.
13. Almeida P.F., Pokorny A. Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry 2009, 48:8083-8093.
14. Matsuzaki K. Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta 2009, 1788:1687-1692.
15. Epand R.M., Epand R.F. Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim. Biophys. Acta 2009, 1788:289-294.
16. Epand R.M., Rotem S., Mor A., Berno B., Epand R.F. Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc. 2008, 130:14346-14352.
17. Arouri A., Dathe M., Blume A. Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes?. Biochim. Biophys. Acta 2009, 1788:650-659.
18. Epand R.F., Wang G., Berno B., Epand R.M. Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37. Antimicrob. Agents Chemother. 2009, 53:3705-3714.
19. Epand R.F., Mowery B.P., Lee S.E., Stahl S.S., Lehrer R.I., Gellman S.H., Epand R.M. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. J. Mol. Biol. 2008, 379:38-50.
20. Jean-Francois F., Castano S., Desbat B., Odaert B., Roux M., Metz-Boutigue M.H., Dufourc E.J. Aggregation of cateslytin beta-sheets on negatively charged lipids promotes rigid membrane domains. A new mode of action for antimicrobial peptides?. Biochemistry 2008, 47:6394-6402.
21. Oreopoulos J., Epand R.F., Epand R.M., Yip C.M. Peptide-induced domain formation in supported lipid bilayers: direct evidence by combined atomic force and polarized total internal reflection fluorescence microscopy. Biophys. J. 2010, 98:815-823.
22. Ellens H., Bentz J., Szoka F.C. H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry 1985, 24:3099-3106.
23. Ames B.N. Assay of inorganic phosphate. Total phosphate and phosphatases 1966, 115-118. Academic Press. E.F. Neufeld, V. Ginsburg (Eds.).
24. Sternberg B. Liposomes as a model for membrane structure and structural transformations: a liposome album. Nonmedical Applications of Liposomes 1996, vol. IV:271-297. CRC Press, Boca Raton.
25. Sternberg B. Freeze-fracture electron microscopy of liposomes. Liposome preparation and related techniques 1993, 363-383. CRC Press, Boca Raton, Liposome Technology. G. Gregoriadis (Ed.).
26. Papahadjopoulos-Sternberg B. Freeze-fracture electron microscopy on domains in lipid mono- and bilayer on nano-resolution scale. Methods Mol. Biol. 2010, 606:333-349.
27. van der Kraan M., van Marle J., Nazmi K., Groenink J., van't Hof W., Veerman E.C.I., Bolscher J.G.M., Amerongen A.V.N. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. Peptides 2005, 26:1537-1542.
28. Papo N., Shai Y. A molecular mechanism for lipopolysaccharide protection of gram-negative bacteria from antimicrobial peptides. J. Biol. Chem. 2005, 280:10378-10387.
29. Mangoni M.L., Epand R.F., Rosenfeld Y., Peleg A., Barra D., Epand R.M., Shai Y. Lipopolysaccharide, a key molecule involved in the synergism between temporins in inhibiting bacterial growth and in endotoxin neutralization. J. Biol. Chem. 2008, 283:22907-22917.
30. Li X., Li Y., Han H., Miller D.W., Wang G. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 2006, 128:5776-5785.
31. Wang G. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 2008, 283:32637-32643.
32. Zorko M., Japelj B., Hafner-Bratkovic I., Jerala R. Expression, purification and structural studies of a short antimicrobial peptide. Biochim. Biophys. Acta (BBA) - Biomembr. 2009, 1788:314-323.
33. Matsumoto K., Kusaka J., Nishibori A., Hara H. Lipid domains in bacterial membranes. Mol. Microbiol. 2006, 61:1110-1117.
34. Epand R.M., Epand R.F. Domains in bacterial membranes and the action of antimicrobial agents. Mol. BioSyst. 2009, 5:580-587.
35. Rosch J.W., Hsu F.F., Caparon M.G. Anionic lipids enriched at the ExPortal of Streptococcus pyogenes. J. Bacteriol. 2007, 189:801-806.
36. Shaw N. Bacterial glycolipids. Bacteriol. Rev. 1970, 34:365-377.
37. Peschel A., Jack R.W., Otto M., Collins L.V., Staubitz P., Nicholson G., Kalbacher H., Nieuwenhuizen W.F., Jung G., Tarkowski A., van Kessel K.P., van Strijp J.A. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 2001, 193:1067-1076.
38. Camargo I.L., Neoh H.M., Cui L., Hiramatsu K. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob. Agents Chemother. 2008, 52:4289-4299.
39. Mishra N.N., Yang S.J., Sawa A., Rubio A., Nast C.C., Yeaman M.R., Bayer A.S. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53:2312-2318.
40. Ernst C.M., Staubitz P., Mishra N.N., Yang S.J., Hornig G., Kalbacher H., Bayer A.S., Kraus D., Peschel A. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS. Pathog. 2009, 5:e1000660.
41. Ladokhin A.S., White S.H. Folding of amphipathic alpha-helices on membranes: energetics of helix formation by melittin. J. Mol. Biol. 1999, 285:1363-1369.
42. Rotem S., Radzishevsky I.S., Bourdetsky D., Navon-Venezia S., Carmeli Y., Mor A. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 2008, 22:2652-2661.
43. Radek K.A., Lopez-Garcia B., Hupe M., Niesman I.R., Elias P.M., Taupenot L., Mahata S.K., O'Connor D.T., Gallo R.L. The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J. Invest. Dermatol. 2008, 128:1525-1534.